Coherus Oncology Inc (CHRS)

Change in Working Capital

-$56.40M

Quarterly · Period ending: · USD

CHRS logo

CHRS Change in Working Capital

Latest reported-$56.40M
CHRS Quarterly Change in Working Capital ($779.00K → -$56.40M)
High-resolution chart · PNG

CHRS change in working capital history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc Change in Working Capital — Quarterly (USD)
Period endingChange in Working Capital (USD)
-56,398,000
-23,681,000
-12,793,000
-9,389,000
-23,652,000
10,859,000
54,538,000
-61,530,000
74,264,000
-11,378,000
6,369,000
-27,620,000
-6,229,000
-9,346,000
-54,613,000
8,694,000
-16,221,000
-17,117,000
-20,609,000
32,318,000
24,259,000
6,392,000
5,789,001
5,429,000
-15,127,000
-34,030,000
-42,146,000
-2,830,000
-20,476,000
-48,476,000
5,452,000
2,622,000
1,669,000
554,000
2,124,000
7,874,000
-7,304,000
-7,827,000
-20,294,000
-153,549,000
30,439,000
-15,810,000
50,633,000
6,186,000
33,125,000
1,171,000
-11,294,000
-1,962,000
16,587,000
25,103,000
15,075,000
27,029,000
1,454,000
779,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.